James Maher, MD
Cardiovascular Disease · Rock Hill, SCNPI 1235334145
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations.
Across 176 payments — averaging $34.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Abiomed$772
- Novartis$617
- E.r. Squibb & Sons, L.L.C.$330
- Penumbra, Inc.$285
- Bayer$280
- plus $3K from 26 others
Across 2 payments — averaging $19,566 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$39K
What the payments were for
- Food & beverage$6,086100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 34 | $1,293 |
| Abiomed | 9 | $772 |
| Novartis | 33 | $617 |
| E.r. Squibb & Sons, L.L.C. | 17 | $330 |
| Penumbra, Inc. | 2 | $285 |
| Bayer | 4 | $280 |
| AstraZeneca | 5 | $275 |
| Edwards Lifesciences | 2 | $213 |
| Pfizer | 6 | $195 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $168 |
| Cvrx, Inc. | 9 | $163 |
| Cardiva Medical, Inc. | 11 | $156 |
| Atricure, Inc. | 2 | $150 |
| Boehringer Ingelheim | 2 | $139 |
| Inspire Medical Systems, Inc. | 1 | $139 |
| Merck | 6 | $133 |
| Scpharmaceuticals Inc. | 1 | $125 |
| Inari Medical, Inc. | 1 | $117 |
| Amgen | 5 | $84 |
| Stryker | 1 | $71 |
| Acist Medical Systems, Inc. | 2 | $53 |
| Tactile Systems Technology Inc | 2 | $49 |
| Biotronik Inc. | 1 | $48 |
| Esperion Therapeutics, Inc. | 2 | $47 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Amarin Pharma, Inc. | 2 | $38 |
| Lexicon Pharmaceuticals, Inc. | 2 | $30 |
| Chiesi USA, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Cleerly, Inc. | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$605
- Indigo System$285
- Kerendia$240
- FARXIGA$238
- Inspire$139
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$130
- Edwards SAPIEN 3 Transcatheter Heart Valve$126
- FUROSCIX$125
- CardioMEMS HF System$120
- VYNDAQEL$120
- CARDIOMEMS$118
- FLOWTRIEVER CATHETER, S$117
- CT THROMBECTOMY SYSTEM KIT$117
- JARDIANCE$111
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$109
- Diamondback Peripheral$104
How this compares
$6,086 in reported general payments places this provider in the 60th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 449 | $478,345 |
| CamzyosMavacamten | 31 | $230,716 |
| EntrestoSacubitril/Valsartan | 102 | $138,565 |
| FarxigaDapagliflozin Propanediol | 111 | $121,002 |
| JardianceEmpagliflozin | 128 | $105,334 |
| XareltoRivaroxaban | 71 | $79,921 |
| Repatha SureclickEvolocumab | 38 | $37,548 |
| BrilintaTicagrelor | 17 | $18,665 |
| VerquvoVericiguat | 13 | $15,128 |
| Rosuvastatin Calcium | 466 | $5,566 |
| Metoprolol Succinate | 442 | $5,252 |
| Clonidine | 29 | $4,431 |
| Ranolazine ErRanolazine | 65 | $4,354 |
| Flecainide Acetate | 110 | $4,226 |
| Losartan Potassium | 288 | $2,941 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $195 | $478,345449 claims |
| E.r. Squibb & Sons, L.L.C.Camzyos | $330 | $230,71631 claims |
| AstraZenecaFarxiga, Brilinta | $275 | $139,666128 claims |
| NovartisEntresto | $617 | $138,565102 claims |
| Boehringer IngelheimJardiance | $139 | $105,334128 claims |
| Johnson & JohnsonXarelto | $16 | $79,92171 claims |
| MerckVerquvo | $133 | $15,12813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 257 cardiovascular disease providers in South Carolina.
Other cardiovascular disease in Rock Hill
- Murad AbdelsalamRock Hill$21K
- Robert BiedermanCharleston$775K
- Darren SidneyNorth Charleston$129K
- Priyanka BhattacharyaCharleston$107K
- Gregory SanGreenville$88K
- David McNeelyGreenville$78K
- Gregory EavesAiken$65K
- James SmithCharleston$64K
- Christopher SalmonGreenville$54K
- Ricky HendersonAnderson$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.